Cita APA

Shane, E., Cohen, A., Stein, E. M., McMahon, D. J., Zhang, C., Young, P., . . . Mancini, D. (2012). Zoledronic Acid Versus Alendronate for the Prevention of Bone Loss after Heart or Liver Transplantation. Endocrine Society.

Citación estilo Chicago

Shane, Elizabeth, et al. Zoledronic Acid Versus Alendronate for the Prevention of Bone Loss After Heart or Liver Transplantation. Endocrine Society, 2012.

Cita MLA

Shane, Elizabeth, et al. Zoledronic Acid Versus Alendronate for the Prevention of Bone Loss After Heart or Liver Transplantation. Endocrine Society, 2012.